$TECH Cashflow Statement | Understand Stock

$TECH

$72.60 -$0.09 (0.12%) Close

$TECH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization
Costs recognized on sale of acquired inventory
Deferred income taxes
Stock-based compensation expense
Fair value adjustment to contingent consideration payable
Contingent consideration payments - operating
Gain on sale of CCXI investment
Fair value adjustment on available-for-sale investments
(Gain) Loss on equity method investment
Loss on investments
Asset impairment restructuring
Eminence impairment
Gain on sale of Eminence
Leases, net
(Recovery) Impairment of assets held-for-sale
Other operating activity
Change in operating assets and operating liabilities:
Trade accounts and other receivables, net
Inventories
Prepaid expenses
Trade accounts payable, accrued expenses, contract liabilities, and other
Salaries, wages and related accruals
Income taxes payable
Net cash provided by operating activities

CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of available-for-sale investments
Purchases of available-for-sale investments
Proceeds from sale of CCXI investment
Additions to property and equipment
Acquisitions, net of cash acquired
Proceeds from sale of Eminence
Investment of forward purchase contract
Investment in Wilson Wolf
Distributions from Wilson Wolf
Investment in Spear Bio
Proceeds from sale of assets held-for-sale
Net cash used in investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Cash dividends
Proceeds from stock option exercises
Repurchases of common stock
Borrowings under line-of-credit agreement
Repayments of long-term debt
Contingent consideration payments - financing
Taxes paid on RSUs and net share settlements
Other financing activity
Net cash used in financing activities

Effect of exchange rate changes on cash and cash equivalents
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Cash paid for interest

Comments